» Articles » PMID: 16436722

Quinolones Induce Partial or Total Loss of Pathogenicity Islands in Uropathogenic Escherichia Coli by SOS-dependent or -independent Pathways, Respectively

Overview
Specialty Pharmacology
Date 2006 Jan 27
PMID 16436722
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Escherichia coli is the most common microorganism causing urinary tract infections. Quinolone-resistant E. coli strains have fewer virulence factors than quinolone-susceptible strains. Several urovirulence genes are located in pathogenicity islands (PAIs). We investigated the capacity of quinolones to induce loss of virulence factors such as hemolysin, cytotoxic necrotizing factor 1, P fimbriae, and autotransporter Sat included in PAIs in three uropathogenic E. coli strains. In a multistep selection, all strains lost hemolytic capacity at between 1 and 4 passages when they were incubated with subinhibitory concentrations of ciprofloxacin, showing a partial or total loss of the PAI containing the hly (hemolysin) and cnf-1 (cytotoxic necrotizing factor 1) genes. RecA(-) mutants were obtained from the two E. coli strains with partial or total loss of the PAI. The inactivation of the RecA protein affected only the partial loss of the PAI induced by quinolones. No spontaneous loss of PAIs was observed on incubation in the absence of quinolones in either the wild-type or mutant E. coli strains. Quinolones induce partial or total loss of PAIs in vitro in uropathogenic E. coli by SOS-dependent or -independent pathways, respectively.

Citing Articles

Resistant Escherichia coli isolated from wild mammals from two rescue and rehabilitation centers in Costa Rica: characterization and public health relevance.

Fernandes R, Abreu R, Serrano I, Such R, Garcia-Vila E, Quiros S Sci Rep. 2024; 14(1):8039.

PMID: 38580725 PMC: 10997758. DOI: 10.1038/s41598-024-57812-6.


Genotypic Characterization of Uropathogenic from Companion Animals: Predominance of ST372 in Dogs and Human-Related ST73 in Cats.

Aurich S, Wolf S, Prenger-Berninghoff E, Thrukonda L, Semmler T, Ewers C Antibiotics (Basel). 2024; 13(1).

PMID: 38247597 PMC: 10812829. DOI: 10.3390/antibiotics13010038.


Metabolic and Morphotypic Trade-Offs within the Eco-Evolutionary Dynamics of Escherichia coli.

Zlatkov N, Nasman M, Uhlin B Microbiol Spectr. 2022; 10(5):e0067822.

PMID: 36169422 PMC: 9602443. DOI: 10.1128/spectrum.00678-22.


Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility.

Derakhshan S, Ahmadi S, Ahmadi E, Nasseri S, Aghaei A BMC Microbiol. 2022; 22(1):89.

PMID: 35387587 PMC: 8985246. DOI: 10.1186/s12866-022-02506-0.


Virulence factors and antimicrobial resistance of uropathogenic Escherichia coli (UPEC) isolated from urinary tract infections: a systematic review and meta-analysis.

Bunduki G, Heinz E, Phiri V, Noah P, Feasey N, Musaya J BMC Infect Dis. 2021; 21(1):753.

PMID: 34348646 PMC: 8336361. DOI: 10.1186/s12879-021-06435-7.


References
1.
Hacker J, Kaper J . Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol. 2000; 54:641-79. DOI: 10.1146/annurev.micro.54.1.641. View

2.
Johnson J, Stell A . Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 1999; 181(1):261-72. DOI: 10.1086/315217. View

3.
Martinez-Martinez L, Fernandez F, Perea E . Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli. J Antimicrob Chemother. 2001; 43(2):277-9. DOI: 10.1093/jac/43.2.277. View

4.
Houdouin V, Bonacorsi S, Brahimi N, Clermont O, Nassif X, Bingen E . A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis. Infect Immun. 2002; 70(10):5865-9. PMC: 128312. DOI: 10.1128/IAI.70.10.5865-5869.2002. View

5.
Vila J, Simon K, Ruiz J, Horcajada J, Velasco M, Barranco M . Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J Infect Dis. 2002; 186(7):1039-42. DOI: 10.1086/342955. View